Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENLIUS

33.950
+1.9506.09%
Volume:2.44M
Turnover:82.64M
Market Cap:18.45B
PE:21.15
High:35.450
Open:32.150
Low:32.000
Close:32.000
Loading ...

Henlius Gets Chinese Regulator's Approval for Clinical Trial of Tumor Drug

MT Newswires Live
·
04 Dec 2024

Henlius Secures Chinese Regulator's Nod for New Drug Application for Breast Cancer Treatment

MT Newswires Live
·
04 Dec 2024

Shanghai Henlius Biotech's NDA for Lung Cancer Drug's New Indication Gets Chinese Regulator's Nod

MT Newswires Live
·
04 Dec 2024

BRIEF-Shanghai Henlius Biotech Inc's Application For Phase 1B/2 Clinical Trial Of HLX43- For Injection Approved By NMPA

Reuters
·
04 Dec 2024

BRIEF-Shanghai Henlius Biotech Says New Drug Application For Pertuzumab Biosimilar- HLX11 Accepted By NMPA

Reuters
·
04 Dec 2024

Shanghai Henlius Biotech Inc - Application for Phase 1B/2 Clinical Trial of Hlx43- for Injection Approved by Nmpa

THOMSON REUTERS
·
04 Dec 2024

Shanghai Henlius Biotech - Nda for New Indication of Hansizhuang (Serplulimab Injection) in Combination With Chemotherapy Approved by Nmpa

THOMSON REUTERS
·
04 Dec 2024

Shanghai Henlius Biotech Inc - New Drug Application for Pertuzumab Biosimilar- Hlx11 Accepted by Nmpa

THOMSON REUTERS
·
04 Dec 2024

New Indication of Henlius' Lung Cancer Drug Given Green Light by Chinese Regulator

MT Newswires Live
·
03 Dec 2024

BRIEF-Shanghai Henlius Biotech Says NMPA Approved NDA For New Indication Of Hansizhuang

Reuters
·
03 Dec 2024

Shanghai Henlius Biotech - Nda for New Indication of Hansizhuang in Combination With Chemotherapy Approved by Nmpa

THOMSON REUTERS
·
03 Dec 2024

Henlius Doses First Patient in Phase 3 Study of Combo Treatment for Gastric Cancer

MT Newswires Live
·
22 Nov 2024

BRIEF-Henlius Says It Entered Strategic Collaboration With Al-Tiryaq Al-Khalawi Medical Company

Reuters
·
09 Nov 2024

Henlius: on Morning of Nov 7, Entered Into a Strategic Collaboration With Al-Tiryaq Al-Khalawi Medical Company

THOMSON REUTERS
·
09 Nov 2024

Henlius: Co and Svax Forge Strategic Partnership in Menat Market, Will Establish Joint Ventures in Saudi Arabia

THOMSON REUTERS
·
09 Nov 2024

Henlius to Establish Saudi Arabia JVs to Distribute Drugs to Middle East

MT Newswires Live
·
08 Nov 2024

BRIEF-Shanghai Henlius Biotech Says Biologics License Application For Biosimilar Of Denosumab Hlx14 Accepted By Us FDA

Reuters
·
30 Oct 2024

US FDA Accepts Biologics License Application (Bla) for Hlx14, Biosimilar Candidate of Prolia/Xgeva (Denosumab)

THOMSON REUTERS
·
30 Oct 2024

Shanghai Henlius Biotech - Biologics License Application for Biosimilar of Denosumab Hlx14 Accepted by US FDA

THOMSON REUTERS
·
30 Oct 2024

Shanghai Henlius Biotech Doses 1st Patient in Metastatic Colorectal Cancer Drug in Japan

MT Newswires Live
·
24 Oct 2024